Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the flinders sensitive line rat: A genetic rodent model of depression

Neuropsychopharmacology

Volumn 36, Issue 8, 2011, Pages 1769-1777

  Hascup, Kevin N ^a   Hascup, Erin R ^a   Stephens, Michelle L ^b   Glaser, Paul E A ^b   Yoshitake, Takashi ^a   Mathé, Aleksander A ^a   Gerhardt, Greg A ^b   Kehr, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

antidepressant; basal glutamate; biosensor; electrode; freely moving; major depressive disorder

Indexed keywords

GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DYNAMICS; GENETIC MODEL; MAJOR DEPRESSION; MALE; MICROELECTRODE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

AGE FACTORS; ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; RATS; RATS, MUTANT STRAINS; REST; TIME FACTORS;

EID: 79958804766     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.60     Document Type: Article

References (54)

1. 2+ signaling. Science 327: 1250-1254.
2. Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993). Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150: 1731-1733. (Pubitemid 23325960)
3. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000). Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354. (Pubitemid 30109248)
4. Braw Y, Malkesman O, Dagan M, Bercovich A, Lavi-Avnon Y, Schroeder M et al (2006). Anxiety-like behaviors in pre-pubertal rats of the flinders sensitive line (FSL) and Wistar-Kyoto (WKY) animal models of depression. Behav Brain Res 167: 261-269. (Pubitemid 43099788)
5. Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP et al (2010). Rapid enhancement of glutamatergic neuro-transmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35: 834-846.
6. Burmeister JJ, Coates TD, Gerhardt GA (2004). Multisite micro-electrode arrays for measurements of multiple neurochemicals. Conf Proc IEEE Eng Med Biol Soc 7: 5348-5351. (Pubitemid 40035067)
7. Burmeister JJ, Gerhardt GA (2001). Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem 73: 1037-1042. (Pubitemid 32204921)
8. Burmeister JJ, Moxon K, Gerhardt GA (2000). Ceramic-based multisite microelectrodes for electrochemical recordings. Anal Chem 72: 187-192. (Pubitemid 30027755)
9. Burmeister JJ, Pomerleau F, Palmer M, Day BK, Huettl P, Gerhardt GA (2002). Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS. J Neurosci Methods 119: 163-171. (Pubitemid 35286982)
10. Canbeyli R (2010). Sensorimotor modulation of mood and depression: an integrative review. Behav Brain Res 207: 249-264.
11. Carr DB, Sesack SR (1996). Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369: 1-15. (Pubitemid 26137477)
12. Chen F, Madsen TM, Wegener G, Nyengaard JR (2009). Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 2010: 1376-1384.
13. Danbolt NC (2001). Glutamate uptake. Prog Neurobiol 65: 1-105. (Pubitemid 32479155)
14. Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E et al (2009). Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 66: 275-282.
15. Hascup ER, af BS, Hascup KN, Pomerleau F, Huettl P, Stromberg I et al (2009). Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex. Brain Res 1291: 12-20.
16. Hascup ER, Hascup KN, Stephens M, Pomerleau F, Huettl P, Gratton A et al (2010). Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem 115: 1608-1620.
17. Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA (2008). Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 324: 725-731. (Pubitemid 351185870)
18. Hascup KN, Rutherford EC, Quintero JE, Day BK, Nickell JR, Pomerleau F, Huettl P, Burmeister JJ, Gerhardt GA (2006). Second-by-second measures of L-glutamate and other neuro-transmitters using enzyme-based microelectrode arrays. In: Michael AC and Borland LM (eds). Electrochemical Methods for Neuroscience. CRC Press: Boca Raton FL. pp 407-450.
19. Hashimoto K, Sawa A, Iyo M (2007). Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62: 1310-1316. (Pubitemid 350060893)
20. Insel TR, Wang PS (2009). The STAR*D trial: revealing the need for better treatments. Psychiatr Serv 60: 1466-1467.
21. Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982). Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232: 299-304. (Pubitemid 13124834)
22. Kugaya A, Sanacora G (2005). Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10: 808-819. (Pubitemid 41531934)
23. Kulkarni SK, Dhir A (2009). Current investigational drugs for major depression. Expert Opin Investig Drugs 18: 767-788.
24. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al (2010). mTOR-dependent synapse formation underlies the rapid anti-depressant effects of NMDA antagonists. Science 329: 959-964.
25. Maeng S, Zarate Jr CA (2007). The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antide-pressant effects. Curr Psychiatry Rep 9: 467-474. (Pubitemid 350284937)
26. Malkesman O, Weller A (2009). Two different putative genetic animal models of childhood depression-a review. Prog Neuro-biol 88: 153-169.
27. Matrisciano F, Caruso A, Orlando R, Marchiafava M, Bruno V, Battaglia G et al (2008). Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology 55: 525-531.
28. Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M et al (1998). Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37: 124-129. (Pubitemid 28171767)
29. McCauley E, Myers K, Mitchell J, Calderon R, Schloredt K, Treder R (1993). Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry 32: 714-722. (Pubitemid 23187768)
30. McNally L, Bhagwagar Z, Hannestad J (2008). Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 13: 501-510. (Pubitemid 351965454)
31. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby Jr CR, Kawahara R (2006). Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 30: 1155-1158. (Pubitemid 43928219)
32. Mitchell ND, Baker GB (2010). An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand 122: 192-210.
33. Nickell J, Pomerleau F, Allen J, Gerhardt GA (2005). Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fischer 344 rats. J Neural Transm 112: 87-96. (Pubitemid 40104719)
34. Nierenberg AA (2001). Do some antidepressants work faster than others? J Clin Psychiatry 62(Suppl 15): 22-25. (Pubitemid 32601345)
35. Overstreet DH (1993). The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17: 51-68. (Pubitemid 23068942)
36. Overstreet DH, Friedman E, Mathe AA, Yadid G (2005). The Flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29: 739-759. (Pubitemid 40762598)
37. Overstreet DH, Janowsky DS, Pucilowski O, Rezvani AH (1994). Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breeds of Flinders line rats. Psychiatr Genet 4: 101-107. (Pubitemid 24254328)
38. Overstreet DH, Keeney A, Hogg S (2004). Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. Eur J Pharmacol 492: 195-201. (Pubitemid 38721372)
39. Overstreet DH, Rezvani AH, Janowsky DS (1990). Impaired active avoidance responding in rats selectively bred for increased cholinergic function. Physiol Behav 47: 787-788. (Pubitemid 20146772)
40. Overstreet DH, Russell RW (1982). Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 78: 150-155. (Pubitemid 13234094)
41. Paul IA, Skolnick P (2003). Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003: 250-272. (Pubitemid 38083061)
42. Paxinos G, Watson C. (1998). The Rat Brain: Stereotaxic Coordinates. Academic Press: New York.
43. Pittenger C, Sanacora G, Krystal JH (2007). The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets 6: 101-115. (Pubitemid 46681771)
44. Pollak DD, Rey CE, Monje FJ (2010). Rodent models in depression research: classical strategies and new directions. Ann Med 42: 252-264.
45. Rakofsky JJ, Holtzheimer PE, Nemeroff CB (2009). Emerging targets for antidepressant therapies. Curr Opin Chem Biol 13: 291-302.
46. Rutherford EC, Pomerleau F, Huettl P, Stromberg I, Gerhardt GA (2007). Chronic second-by-second measures of L-glutamate in the central nervous system of freely moving rats. J Neurochem 102: 712-722. (Pubitemid 47057300)
47. Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, Coric V et al (2007). Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry 61: 822-825. (Pubitemid 46330247)
48. Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, Ende G (2007). Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. Neuroreport 18: 1469-1473. (Pubitemid 47295947)
49. Skolnick P, Popik P, Trullas R (2009). Glutamate-based anti-depressants: 20 years on. Trends Pharmacol Sci 30: 563-569.
50. Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A et al (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US food and drug administration. BMJ 339: b2880.
51. Takahashi K, Murasawa H, Yamaguchi K, Yamada M, Nakatani A, Yoshida M et al (2011). Riluzole rapidly attenuates hyperemo-tional responses in olfactory bulbectomized rats, an animal model of depression. Behav Brain Res 216: 46-52.
52. Terracciano A, Tanaka T, Sutin AR, Sanna S, Deiana B, Lai S et al (2010). Genome-wide association scan of trait depression. Biol psychiatry 68: 811-817.
53. Witkin JM, Marek GJ, Johnson BG, Schoepp DD (2007). Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol Disord Drug Targets 6: 87-100. (Pubitemid 46681770)
54. Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I et al (2000). Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol 62: 353-378. (Pubitemid 30336473)